Found 45 results in Expert Content

Summary: Learn about the end-to-end capabilities of Catalent’s inhalation network, supporting the development and manufacture of formulations delivered by Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs) and unit- or bi-dose nasal sprays.

Summary: It is vital that drug products reach patients uncontaminated and unadulterated by their packaging. Extractables and leachables (E&L) are especially of concern for liquid injectable...

Define key aspects of product performance which must be met when developing a generic pMDI.

Explore the challenges with delivering drugs less invasively.

The future of non-invasive delivery technologies for large molecules.